| Multi-omic measurements of heterogeneity in HeLa cells across laboratories Y Liu, Y Mi, T Mueller, S Kreibich, EG Williams, A Van Drogen, C Borel, ... Nature biotechnology 37 (3), 314-322, 2019 | 297 | 2019 |
| Der1 promotes movement of misfolded proteins through the endoplasmic reticulum membrane M Mehnert, T Sommer, E Jarosch Nature cell biology 16 (1), 77-86, 2014 | 176 | 2014 |
| Protein dislocation from the ER K Bagola, M Mehnert, E Jarosch, T Sommer Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (3), 925-936, 2011 | 171 | 2011 |
| ERAD ubiquitin ligases: multifunctional tools for protein quality control and waste disposal in the endoplasmic reticulum M Mehnert, T Sommer, E Jarosch Bioessays 32 (10), 905-913, 2010 | 90 | 2010 |
| Kinase interaction network expands functional and disease roles of human kinases M Buljan, R Ciuffa, A van Drogen, A Vichalkovski, M Mehnert, ... Molecular cell 79 (3), 504-520. e9, 2020 | 72 | 2020 |
| The interplay of Hrd3 and the molecular chaperone system ensures efficient degradation of malfolded secretory proteins M Mehnert, F Sommermeyer, M Berger, S Kumar Lakshmipathy, R Gauss, ... Molecular biology of the cell 26 (2), 185-194, 2015 | 44 | 2015 |
| Combining rapid data independent acquisition and CRISPR gene deletion for studying potential protein functions: a case of HMGN1 M Mehnert, W Li, C Wu, B Salovska, Y Liu Proteomics 19 (13), 1800438, 2019 | 30 | 2019 |
| Multi-layered proteomic analyses decode compositional and functional effects of cancer mutations on kinase complexes M Mehnert, R Ciuffa, F Frommelt, F Uliana, A van Drogen, K Ruminski, ... Nature communications 11 (1), 3563, 2020 | 29 | 2020 |
| Novel biochemical, structural, and systems insights into inflammatory signaling revealed by contextual interaction proteomics R Ciuffa, F Uliana, J Mannion, M Mehnert, T Tenev, C Marulli, ... Proceedings of the National Academy of Sciences 119 (40), e2117175119, 2022 | 11 | 2022 |
| Phosphorylation‐linked complex profiling identifies assemblies required for Hippo signal integration F Uliana, R Ciuffa, R Mishra, A Fossati, F Frommelt, S Keller, M Mehnert, ... Molecular systems biology 19 (4), e11024, 2023 | 4 | 2023 |
| Discovery and validation of therapeutic targets in immune cells by mass spectrometry-based proteomics YW Au, D Satijn, M Mehnert, A Lachaud, Y Feng, J Vowinckel, H Bon Cancer Research 83 (7_Supplement), 3974-3974, 2023 | 1 | 2023 |
| Analysis of the interferon-γ-induced secretome of intestinal endothelial cells: putative impact on epithelial barrier dysfunction in IBD E Naschberger, C Flierl, J Huang, L Erkert, R Gamez-Belmonte, ... Frontiers in Cell and Developmental Biology 11, 2023 | 1 | 2023 |
| Systematic dissection of phosphorylation-dependent YAP1 complex formation elucidates a key role for PTPN14 in Hippo signal integration F Uliana, R Ciuffa, R Mishra, A Fossati, F Frommelt, M Mehnert, ... bioRxiv, 2022.03. 13.484137, 2022 | 1 | 2022 |
| Die Funktion der HRD-Ubiquitinligase bei der Protein-Dislokation aus dem endoplasmatischen Retikulum M Mehnert Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2013 | 1 | 2013 |
| Extracellular matrix remodeling in metastatic mismatch repair deficient endometrial cancer: Implications for immune checkpoint inhibitor response prediction JF Grau, C Aimé, M Mehnert, E Yaniz-Galende, C Genestie, AL Formal, ... Cancer Research 84 (6_Supplement), 5149-5149, 2024 | | 2024 |
| Identification of cancer specific extracellular vesical biomarkers to aid in diagnosis of cancer TA Hembrough, Z Opheim, C Bandoski, I Isaac, M Mehnert, A Ezrin Cancer Research 84 (6_Supplement), 3746-3746, 2024 | | 2024 |
| Assessment of Ultra-Deep Mass Spectrometry Based Proteomics Compared to Flow Cytometry and RNA-Based Methods for the Discovery and Validation of Therapeutic Targets in Immune Cells YW Au, G Rigter, W Yu, D Satijn, M Mehnert, A Lachaud, J Vowinckel, ... Blood 142, 5377, 2023 | | 2023 |
| 1008 Validation of expression of therapeutic targets in T cells and Macrophages by mass spectrometry based proteomics YW Au, MG Navarro, G Rigter, R Van der Windt, J Bakema, J Neijssen, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Global mapping of pathway modules and phosphorylation networks in PDX and corresponding organoid (PDXO) models treated with targeted therapies M Mehnert, X Xu, T Treiber, L Shang, L Chen, J Wang, M Tognetti, ... Cancer Research 83 (7_Supplement), 185-185, 2023 | | 2023 |
| Identification of the phosphorylation network in PDX and corresponding organoid (PDXO) models upon targeted therapy treatment using deep phosphoproteomic analysis [MB1] X Xu, M Tognetti, Y Feng, L Shang, L Chen, J Wang, R Bruderer, L Bourré, ... Cancer Research 82 (12), 2022 | | 2022 |
